DEA Diversion Enforcement News - May 2023

U.S. Drug Enforcement Administration sent this bulletin at 05/02/2023 10:05 AM EDT

Having trouble viewing this email? View it as a Web page.

DEA Diversion Enforcement News

DEA’s Diversion Control Division strives to prevent, detect, and investigate the diversion of controlled pharmaceuticals and listed chemicals from legitimate sources. When the safety and health of the American people is in jeopardy, DEA takes action against those who violate the law.

Read the latest enforcement cases and civil actions:

April 28, 2023

Former Paramedic Sentenced to Three Years in Prison for Stealing Medical-Grade Fentanyl

April 26, 2023

New Jersey Doctor Admits Health Care Fraud Targeting Amtrak

April 12, 2023

Physician and Clinic Office Manager Convicted of Unlawfully Distributing Over 600,000 Opioid Pills

April 9, 2023

Santa Rosa Doctor Sentenced to More than Two Years in Prison for Unlawfully Prescribing Fentanyl and Oxycodone

March 29, 2023

Former Health Care Worker Sentenced for Fentanyl Thefts

Read More

Follow DEA on social media @DEAHQ

You have received this e-mail because you have asked to be notified of changes to the U.S. Department of Justice Web site. Update your subscription to this service, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. If you have questions about the Department of Justice Web site, please contact webmaster@usdoj.gov.

GovDelivery is providing this service on behalf of the Department of Justice and may not use your subscription information for any other purposes.

Department of Justice Privacy Policy
GovDelivery Privacy Policy